Title | Nucleic Acid Therapeutics |
Abbreviation | Nucleic Acid Ther. |
Publication Type | Journal |
Subject Area, Categories, Scope | Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1) |
h-index | 73 |
Overall Rank/Ranking | 2164 |
SCImago Journal Rank (SJR) | 1.490 |
Impact Score | 3.95 |
Publisher | Mary Ann Liebert Inc. |
Country | United States |
ISSN | 21593345, 21593337 |
Best Quartile | Q1 |
Coverage History | 2011-2022 |
Nucleic Acid Therapeutics is a journal covering the technologies/fields/categories related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1). It is published by Mary Ann Liebert Inc.. The overall rank of Nucleic Acid Therapeutics is 2164. According to SCImago Journal Rank (SJR), this journal is ranked 1.490. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 73. The best quartile for this journal is Q1.
The ISSN of Nucleic Acid Therapeutics journal is 21593345, 21593337. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. Nucleic Acid Therapeutics is cited by a total of 472 articles during the last 3 years (Preceding 2022).
The Impact IF 2022 of Nucleic Acid Therapeutics is 3.95, which is computed in 2023 as per its definition. Nucleic Acid Therapeutics IF is decreased by a factor of 0.67 and approximate percentage change is -14.5% when compared to preceding year 2021, which shows a falling trend. The impact IF, also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
Impact IF 2022 of Nucleic Acid Therapeutics is 3.95. If the same downward trend persists, Impact IF may fall in 2023 as well.
Year | Impact IF |
---|---|
2023/2024 | Coming Soon |
2022 | 3.95 |
2021 | 4.62 |
2020 | 4.96 |
2019 | 5.61 |
2018 | 3.88 |
2017 | 2.46 |
2016 | 2.54 |
2015 | 2.97 |
2014 | 3.09 |
Nucleic Acid Therapeutics has an h-index of 73. It means 73 articles of this journal have more than 73 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of Nucleic Acid Therapeutics is 21593345, 21593337. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of Nucleic Acid Therapeutics is 2164. According to SCImago Journal Rank (SJR), this journal is ranked 1.490. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
Year | SJR |
---|---|
2023/2024 | Coming Soon |
2022 | 1.490 |
2021 | 1.566 |
2020 | 2.255 |
2019 | 2.176 |
2018 | 1.488 |
2017 | 1.794 |
2016 | 1.223 |
2015 | 1.618 |
2014 | 1.239 |
Year | Ranking |
---|---|
2023/2024 | Coming Soon |
2022 | 2164 |
2021 | 1950 |
2020 | 1091 |
2019 | 1135 |
2018 | 2275 |
2017 | 1669 |
2016 | 3263 |
2015 | 2099 |
2014 | 3161 |
Nucleic Acid Therapeutics is published by Mary Ann Liebert Inc.. It's publishing house is located in United States. Coverage history of this journal is as following: 2011-2022. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of Nucleic Acid Therapeutics is Nucleic Acid Ther.. This abbreviation ('Nucleic Acid Ther.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Biochemistry (Q1); Drug Discovery (Q1); Genetics (Q1); Molecular Biology (Q1); Molecular Medicine (Q1), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
Nucleic Acid Therapeutics latest impact IF is 3.95. It's evaluated in the year 2022. The highest and the lowest impact IF or impact score of this journal are 5.61 (2019) and 2.46 (2017), respectively, in the last 9 years. Moreover, its average IS is 3.79 in the previous 9 years.
The Nucleic Acid Therapeutics has an SJR (SCImago Journal Rank) of 1.490, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 2.255 in 2020 and the lowest being 1.223 in 2016. Furthermore, the average SJR of the Nucleic Acid Therapeutics over the previous 9-year period stands at 3.79.
The latest h-index of the Nucleic Acid Therapeutics is 73.
The Nucleic Acid Therapeutics is published by the Mary Ann Liebert Inc., with its country of publication being the United States.
The Nucleic Acid Therapeutics is currently ranked 2164 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 1091 in 2020 and its lowest position of 3263 in 2016.
The standard ISO4 abbreviation for the Nucleic Acid Therapeutics is Nucleic Acid Ther..
Nucleic Acid Therapeutics is classified as a journal that the Mary Ann Liebert Inc. publishes.
The Nucleic Acid Therapeutics encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The Nucleic Acid Therapeutics is assigned the following International Standard Serial Numbers (ISSN): 21593345, 21593337.
The best quartile for the Nucleic Acid Therapeutics is Q1 (2022).
The Nucleic Acid Therapeutics coverage history can be summarized as follows: 2011-2022.
Journal/Conference/Workshop/Book Title | Type | Ranking | Publisher | h-index | Impact Score |
---|---|---|---|---|---|
Clinical Medicine and Research | journal | 16602 | Marshfield Clinic | 60 | 1.06 |
Archives of Phytopathology and Plant Protection | journal | 14852 | Taylor and Francis Ltd. | 29 | 1.14 |
International Journal of Applied Linguistics | journal | 7321 | Wiley-Blackwell Publishing Ltd | 51 | 2.00 |
Syntax | journal | 3422 | Wiley-Blackwell Publishing Ltd | 29 | 0.93 |
Indian Phytopathology | journal | 14222 | Springer Nature | 11 | 1.33 |
Oral Radiology | journal | 9461 | Springer Japan | 20 | 2.06 |
Proteomics - Clinical Applications | journal | 9140 | Wiley-VCH Verlag | 59 | 2.02 |
Transboundary and Emerging Diseases | journal | 4279 | Wiley-Blackwell Publishing Ltd | 78 | 4.95 |
Contemporanea | journal | 25908 | Societa Editrice Il Mulino | 5 | 0.11 |
Acta Literaria | journal | 26723 | Universidad de Concepcion | 6 | 0.06 |
Year | Impact Score (IS) |
---|---|
2023/2024 | Coming Soon |
2022 | 3.95 |
2021 | 4.62 |
2020 | 4.96 |
2019 | 5.61 |
2018 | 3.88 |
2017 | 2.46 |
2016 | 2.54 |
2015 | 2.97 |
2014 | 3.09 |